| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00780325 Details | 2014-02-06 Interventional | 1 | [2 Refs] | 26 | Acetazolamide Celecoxib Naproxen Healthy Volunte… | A total of three parts were planned for this study. The sponsor funded only Part 1, so that
neither Part 2 nor Part 3 of this study has been conducted. - | ||
| NCT00004227 Details | 2014-02-06 Interventional | 3 | [4 Refs] | 32 | Cetuximab Head and Neck N… Head and Neck C… | - - | ||
| NCT00113048 Details | 2014-02-05 Interventional | 1 | - | Alemtuzumab Hematologic Neo… Neoplasms Hematologic Mal… | - - | |||
| NCT01933061 Details | 2014-02-04 Interventional | 2 | 0 | Albumin-Bound P… Paclitaxel Melanoma Metastatic Mela… | Strategic decision not to proceed with the opening of this study. There are no concerns over
the safety or quality of the investigational products involved. - | |||
| NCT00832507 Details | 2014-02-04 Interventional | 2 | 162 | Cicletanine Familial Primar… Hypertension Pulmonary Arter… | - - | |||
| NCT00394992 Details | 2014-02-04 Interventional | 3 | 79 | Bevacizumab Capecitabine Oxaliplatin Colorectal Neop… Liver Neoplasms Neoplasm Metast… Colorectal Canc… Liver Metastase… | Data from the C08 study and Avant study - | |||
| NCT01384383 Details | 2014-02-03 Interventional | 2 | 248 | Ledipasvir Hepatitis Hepatitis A Hepatitis C Hepatitis C, Ch… Hepatitis, Chro… Virus Diseases Chronic Hepatit… | - - | |||
| NCT00997672 2009-016377-15 Details | 2014-02-03 Interventional | 2 | 10 | Lithium Carbona… Atrophy Multiple System… Shy-Drager Synd… | Data Monitoring Committee decision on 22nd August 2011 for safety issues Limitation of the study is small sample size of nine randomized patients. This may have determined uneven distribution of AEs due to random variation. Taking into account these limitations, we do not encourage future studies with lithium in MSA. | |||
| NCT00511901 Details | 2014-01-31 Interventional | 4 | 22 | Epoetin Alfa Anemia | Study enrollment was suspended in response to an FDA alert regarding the study drug. The study
was subsequently terminated Limited number of eligible subjects, burdensome protocol requirements impeded recruitment, controversy concerning safety of epoetin alpha which led to early termination of study | |||
| NCT00686478 Details | 2014-01-30 Interventional | 3 | 0 | Interferon alph… Interferon-alph… Interferons Cicatrix, Hyper… Hypertrophy Burn Hypertrophic Sc… | The trial is not being done at this time - | |||
| NCT01288131 Details | 2014-01-29 Interventional | 3 | 8 | Cyclophosphamid… Cyclosporine Cyclosporins Mycophenolic Ac… Anti-r-HuEpo As… | We observed >90 % efficacy in cyclophosphamide and Prednisolone group for treatment of
anti-i-HuEpo associated PRCA - | |||
| NCT00989092 Details | 2014-01-29 Interventional | 2 | [1 Refs] | 287 | Darbepoetin alf… Anemia Neoplasms Anemia of Cance… Cancer Carcinoma Non-Myeloid Mal… | slow enrollment and change in product development strategy - | ||
| NCT00494533 Details | 2014-01-29 Interventional | 4 | 45 | Treprostinil Familial Primar… Hypertension Pulmonary Arter… | Safety issues related to outpatient intravenous infusion in India - | |||
| NCT01677390 Details | 2014-01-28 Interventional | 1 | 4 | Everolimus Carcinoma Carcinoma, Rena… Renal Cell Carc… | - - | |||
| NCT00961753 Details | 2014-01-28 Interventional | 4 | 10 | Ibuprofen Ductus Arterios… Patent Ductus A… | FDA drug recall on July 30, 2010 - | |||
| NCT02015780 2013-003414-40 Details | 2014-01-27 Interventional | 3 | 0 | Hypoglycemic Ag… Diabetes Mellit… Kidney Diseases Renal Insuffici… Chronic Kidney … Type 2 Diabetes… | Due to potential concerns about liver safety (See Detailed Description) - | |||
| NCT00439140 Details | 2014-01-24 Interventional | 3 | 41 | Botulinum Toxin… Botulinum Toxin… abobotulinumtox… Urinary Bladder… Overactive Blad… | In agreement with FDA the study was terminated based on data available. - | |||
| NCT00165594 Details | 2014-01-23 Interventional | 1/2 | - | N-(3-chloro-7-i… Stomach Neoplas… Gastric Cancer | Study was completed. - | |||
| NCT01096199 Details | 2014-01-22 Interventional | 1 | - | Cisplatin Everolimus Cancer | - - | |||
| NCT02040311 Details | 2014-01-20 Interventional | 4 | 701 | Topiramate Weight Loss Obesity | Study was terminated early as sponsor wanted to develop an improved formulation. - |